- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01539434
Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)
Behavioral Medicine Intervention to Maintain Physical Capacity and Level of Physical Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease and the number of patients is increasing. Persons with COPD have a low physical capacity and a low physical activity level. The risk of premature morbidity and mortality is high especially in persons with a low level of physical capacity and activity. Rehabilitation including physical training is recommended and results in decreased morbidity and mortality and increased physical capacity and quality of life. Unfortunately improvements decrease if patients do not maintain their physical activity level.
To change physical activity behaviour in is challenging. Different methods as Social Cognitive Theory, SCT and the Transtheoretical model, TTM have been suggested as theoretical framework. According to SCT, to improve physical activity behaviour you should use goal-setting, outcome expectancy, self-efficacy, and self-monitoring.
To use motivational interviewing (MI) improves the success of a behaviour change.
Patients will be randomized after the 12-week training period, tested, and thereafter both the intervention group and the control group will get information about the importance of physical activity and the recommendations.
Thereafter patients in the intervention group will receive weekly telephone calls for the first month, telephone calls every second week for the following two months and thereafter monthly telephone calls for the following three months. The telephone calls will be in accordance with MI and discuss goal-setting, out-come expectancy, and self-monitoring.
Patients will be tested after 6,12,and 24 months.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Uppsala, Sweden, 75124
- Recruiting
- Uppsala University
-
Contact:
- Margareta Emtner, PhD
- Phone Number: +46184714761
- Email: margareta.emtner@neuro.uu.se
-
Contact:
- Christer Janson, Professor
- Phone Number: +46704250441
- Email: christer.janson@medsci.uu.se
-
Principal Investigator:
- Margareta Emtner, PhD
-
Sub-Investigator:
- Johanna Holmbäck, PT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with COPD at Uppsala and Umeå university hospitals, who have participated in physical training at the hospital for 12 weeks.
- Diagnose of COPD
Exclusion criteria:
- Understand the Swedish language
- Be able to be physically active
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Behavioural intervention
Patients in the behavioural intervention group will get a personal meeting with the physiotherapist and get advice about the value of physical activity and also get recommendations on how to be physically active.
The behavioural intervention to support physical activity behaviour includes weekly motivational interviewing telephone calls for the first month, two telephone calls for the following two months and thereafter monthly telephone calls.
|
Patients in the behavioural intervention group will get a personal meeting with the physiotherapist and get advice about the value of physical activity and also get recommendations on how to be physically active.
The behavioural intervention to support physical activity behaviour includes weekly motivational interviewing telephone calls for the first month, two telephone calls for the following two months and thereafter monthly telephone calls.
Other Names:
|
|
Active Comparator: Usual care group
Patients in the usual care group will get a personal meeting with the physiotherapist and get advice about the value of physical activity and also get recommendations on how to be physically active.
|
Patients in the usual care group will get a personal meeting with the physiotherapist and get advice about the value of physical activity and also get recommendations on how to be physically active.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Six-minute walking distance
Time Frame: Change from baseline and 6 months and up to 24 months
|
Change in six-minute walking distance
|
Change from baseline and 6 months and up to 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity level
Time Frame: Change from baseline and 6 months and up to 24 months
|
Number of steps, energy expenditure, time in different positions
|
Change from baseline and 6 months and up to 24 months
|
|
Short Form 36
Time Frame: Change from baseline and 6 months and up to 24 months
|
Measures health related quality of life
|
Change from baseline and 6 months and up to 24 months
|
|
Chronic Respiratory Disease Questionnaire
Time Frame: Change from baseline and 6 months and up to 24 months
|
Measures health related quality of life
|
Change from baseline and 6 months and up to 24 months
|
|
Hospital anxiety and depression scale
Time Frame: Change from baseline and 6 months and up to 24 months
|
Measures anxiety and depression
|
Change from baseline and 6 months and up to 24 months
|
|
Grippit
Time Frame: Change from baseline and 6 months and up to 24 months
|
Hand muscle strength
|
Change from baseline and 6 months and up to 24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Margareta Emtner, PhD, Uppsala University
- Study Chair: Karin Wadell, PhD, Umeå University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UOU-2012-MEKW
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease, Chronic Obstructive
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Behavioural intervention
-
Tung Wah CollegeThe Hong Kong Polytechnic University; University of SouthamptonNot yet recruitingCognitive Frailty
-
B.P. Koirala Institute of Health SciencesUnknown
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Catala de SalutActive, not recruitingProactive Telemedicine to Improve Healthcare Access and Prevention in Rural Primary Care (PTM) (PTM)Quality of Life | Telemedicine | Primary Health Care | Adverse Effects | Prevention | Brief Intervention | Cardiovascular (CV) Risk | Face to Face Consultation | Health Care Access | Behavior Change InterventionsSpain
-
Kaiser PermanenteArizona State UniversityCompletedObesity | Diabetes | Weight Loss | PreDiabetes
-
Radboud University Medical CenterAssistance Publique - Hôpitaux de Paris; Ludwig-Maximilians - University of... and other collaboratorsCompletedMyotonic Dystrophy Type 1Netherlands, France, Germany, United Kingdom
-
University of ValenciaUnknownGeriatric DisorderSpain
-
Chinese University of Hong KongCompletedDepression | Quality of Life | Anxiety | Hematologic MalignancyEthiopia
-
David Batalla-MartinCompletedSchizophrenia | InsomniaSpain
-
Centre for Addiction and Mental HealthUniversity of Calgary; Douglas Mental Health University Institute; London Health...Active, not recruitingAggression | Alzheimer's Disease | Alzheimer Dementia (AD)Canada
-
Imperial College Healthcare NHS TrustImperial College LondonTerminatedBreast Cancer | Breast DiseaseUnited Kingdom